Dean L Schorno - Net Worth and Insider Trading
Dean L Schorno Net Worth
The estimated net worth of Dean L Schorno is at least $3 Million dollars as of 2024-12-26. Dean L Schorno is the CFO of Genomic Health Inc and owns about 30,673 shares of Genomic Health Inc (GHDX) stock worth over $2 Million. Dean L Schorno is also the EVP & CFO of Rigel Pharmaceuticals Inc and owns about 40,289 shares of Rigel Pharmaceuticals Inc (RIGL) stock worth over $673,834. Details can be seen in Dean L Schorno's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dean L Schorno has not made any transactions after 2024-02-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Dean L Schorno
Dean L Schorno Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dean L Schorno owns 1 companies in total, including Rigel Pharmaceuticals Inc (RIGL) .
Click here to see the complete history of Dean L Schorno’s form 4 insider trades.
Insider Ownership Summary of Dean L Schorno
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RIGL | Rigel Pharmaceuticals Inc | 2024-02-05 | EVP & Chief Financial Officer |
Dean L Schorno Latest Holdings Summary
Dean L Schorno currently owns a total of 2 stocks. Among these stocks, Dean L Schorno owns 30,673 shares of Genomic Health Inc (GHDX) as of June 10, 2014, with a value of $2 Million and a weighting of 74.28%. Dean L Schorno also owns 40,289 shares of Rigel Pharmaceuticals Inc (RIGL) as of February 5, 2024, with a value of $673,834 and a weighting of 25.72%.
Latest Holdings of Dean L Schorno
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GHDX | Genomic Health Inc | 2014-06-10 | 30,673 | 63.44 | 1,945,895 |
| RIGL | Rigel Pharmaceuticals Inc | 2024-02-05 | 40,289 | 16.73 | 673,834 |
Holding Weightings of Dean L Schorno
Dean L Schorno Form 4 Trading Tracker
According to the SEC Form 4 filings, Dean L Schorno has made a total of 0 transactions in Genomic Health Inc (GHDX) over the past 5 years. The most-recent trade in Genomic Health Inc is the sale of 4,000 shares on June 10, 2014, which brought Dean L Schorno around $110,480.
According to the SEC Form 4 filings, Dean L Schorno has made a total of 2 transactions in Rigel Pharmaceuticals Inc (RIGL) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Rigel Pharmaceuticals Inc is the sale of 1,263 shares on February 5, 2024, which brought Dean L Schorno around $14,396.
Insider Trading History of Dean L Schorno
- 1
Dean L Schorno Trading Performance
GuruFocus tracks the stock performance after each of Dean L Schorno's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dean L Schorno is -7.32%. GuruFocus also compares Dean L Schorno's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dean L Schorno within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Dean L Schorno's insider trading performs compared to the benchmark.
Performance of Dean L Schorno
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 12.2 | | | | | |
| Relative Return to S&P 500(%) | 8.9 | | | | | |
Dean L Schorno Ownership Network
Dean L Schorno Owned Company Details
What does Rigel Pharmaceuticals Inc do?
Who are the key executives at Rigel Pharmaceuticals Inc?
Dean L Schorno is the EVP & Chief Financial Officer of Rigel Pharmaceuticals Inc. Other key executives at Rigel Pharmaceuticals Inc include Sr VP of Bus Dev and Com Ops Raul R Rodriguez , EVP & Chief Commercial Officer David A Santos , and EVP & CMO Wolfgang Dummer .
Rigel Pharmaceuticals Inc (RIGL) Insider Trades Summary
Over the past 18 months, Dean L Schorno made 1 insider transaction in Rigel Pharmaceuticals Inc (RIGL) with a net sale of 12,628. Other recent insider transactions involving Rigel Pharmaceuticals Inc (RIGL) include a net sale of 52,894 shares made by Raul R Rodriguez , a net sale of 14,519 shares made by David A Santos ,
In summary, during the past 3 months, insiders sold 0 shares of Rigel Pharmaceuticals Inc (RIGL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 8,004 shares of Rigel Pharmaceuticals Inc (RIGL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 8,004 shares.
Rigel Pharmaceuticals Inc (RIGL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rigel Pharmaceuticals Inc Insider Transactions
Dean L Schorno Mailing Address
Above is the net worth, insider trading, and ownership report for Dean L Schorno. You might contact Dean L Schorno via mailing address: 301 Penobscot Drive, Redwood City Ca 94063.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
